Expanding the use of genomic sequencing for improved cancer treatment

A recent study concluded that universal molecular testing in stage 4 non-small cell lung cancer is a critical first step in determining the best course of treatment; but adoption of next-generation sequencing (NGS) has been slow. Here, Thermo Fisher Scientific’s Dr Luca Quagliata discusses the issues around widespread introduction of NGS and how oncologists and pathologists can use it to improve outcomes for cancer patients.

DPYD screening: precision medicine in clinical practice

Three years on from NHS Wales becoming the first nation within the NHS to recommend DPYD screening to predict a negative response to treatment for all cancer patients prescribed fluoropyrimidine therapy, the All Wales Medical Genomics Service has highlighted some key clinical findings, as well as providing valuable recommendations for institutions or authorities who could benefit from establishing their own service.

How laboratories can overcome the ‘big data’ challenge of genomics

The potential benefits to personalised medicine likely to be offered in the near future by genomics are huge. But to start realising them, laboratories need to overcome the challenge of ‘big data’ which could stop them embracing these new technologies, says Emma Huntridge of Clinisys.

It’s in our DNA: unlocking the genetic code to create a biological revolution

Whole-genome sequencing is a comprehensive method for analysing entire genomes and has been instrumental in identifying, for example, inherited disorders and the mutations that drive cancer development. Here, PerkinElmer genomics specialist Anona Bamford provides an insight into the enigma that is the study of deoxyribonucleic acid.

Molecular detection of Mycobacterium ulcerans strains in Nigeria

Mycobacterium ulcerans infection results in a debilitating disease that is characterised by extensive and severe destruction of the skin and subcutaneous tissue. Adewale Oke and colleagues report on a study that aimed to identify cases of so-called Buruli ulcer in five states of south-west Nigeria.

Viasure extraction kit: first UK validation by Nuffield Hospital

Nucleic acid amplification tests are the model for detecting SARS-CoV-2, but efficient extraction of viral RNA is essential. Here, David Mathias and Lucy Goulart compare the performance and usability of two RNA extraction kits.

Latest Issues